ACL-Healius deal blocked by Australian competition watchdog, despite divestment offer
Australian Clinical Labs’ attempted acquisition of rival pathology services player Healius has been blocked by the country’s competition watchdog, despite the merger parties’ offer to divest a number of key assets...To view the full article, register now.
Already a subscriber? Click here to view full article